May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective study.

BMJ Neurol Open · 2020 · PMC7871707 · PMID 33681794

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Regarding the effects on aura frequency and duration, our results showed a trend towards a better efficacy of lamotrigine compared with topiramate.

also in 53,322 other papers

failed to reach statistical significanceno p-value reported

Responder rates for aura frequency and duration were higher in the lamotrigine group compared with the topiramate group (88% vs 79% and 73% vs 54%, respectively), although these differences failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.